Search

everythinglearnresearchcommunity

for

Search:↓

The study found that a specific genetic variation in the TNFα gene is significantly linked to Alopecia Areata in the Jordanian Arab population.

Telemedicine is effective for managing alopecia areata follow-ups.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Early diagnosis and a strict gluten-free diet are crucial for children with celiac disease to improve symptoms.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

Sarcoidosis is more common and severe in Black patients than in Caucasians, requiring early diagnosis and treatment.

Genetic discoveries are leading to new treatments for alopecia areata.

Certain IL-18 gene variations may increase the risk of alopecia areata.

Thyroid and skin autoimmune diseases share genetic and immune links, affecting both tissues.

Thyroid issues can cause alopecia areata.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

Healthcare access for alopecia areata in the USA is unequal among ethnic groups.

A specific group of immune and skin cells may cause chronic inflammation in atopic dermatitis.

Alopecia Areata affects young adults more in high-income countries, especially females.

Azathioprine can cause unexpected hair loss and severe bone marrow issues, so careful monitoring is needed.

JAK inhibitors show promise for treating Alopecia Areata, but more research is needed for better, accessible treatments.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

The study found that alopecia areata and hypothyroidism increase the risk of each other, but androgenetic alopecia and hypothyroidism do not.

Thyroid problems can cause hair loss and change hair texture.

The symposium highlighted the importance of genetics in understanding and treating complex skin diseases.

Frontal fibrosing alopecia might be linked to autoimmune diseases.

Topical bexarotene 1% gel might help regrow hair in alopecia areata and is generally safe.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

VKHD and sarcoidosis may share a common cause.

People with alopecia areata may have a higher risk of thyroid diseases.

Advancements in diagnostics, treatments, and technology have improved hair loss detection and restoration, with some types being reversible.

ITK inhibitors may effectively treat alopecia areata.

New understanding and treatments for hair loss are improving, but more research is needed.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.